首页>投融资
BillionToOne
未公开
Billiontoone Inc is a developer of a molecular counter platform intended to improve the resolution of cell-free DNA testing. The company's prenatal testing procedure focuses on quantitative biology and statistical learning methods to optimize the signal-to-noise ratio and detect single-gene disorders, enabling expecting mothers to detect disorders such as sickle-cell disease, beta-thalassemia, spinal muscular atrophy, and cystic fibrosis through a simple blood test.In December 2022, Billiontoone Inc announces it has secured an additional $48.5 million of funding from existing equity investors as well as upsized its Term Loan Facility with access to up to $35 million With this additional funding, gross proceeds will reach $280 million.In March 2022, BillionToOne Inc closed an oversubscribed Series C funding round of $125 million with premier global investors
基本信息
-
公司全称Billiontoone Inc
-
类型遗传病检测系统供应商
-
产业领域试剂/耗材、器械/设备
-
公司人数15人以下
-
地址1035 O'brien Drive MENLO PARK CALIFORNIA 94025; US; Telephone: +16504602551;
-
联系电话1650-460-2551
-
邮箱info@billiontoone.com
-
成立时间2016-01-01
投融资
-
2024-09-04未公开1.4亿美元Oberland Capital
-
2024-06-21D轮1.3亿美元PremjiInvestAdam Street PartnersBaillie GiffordHummingbirdCivilization VenturesLibertus CapitalFifty YearsNeuberger Berman
-
2022-03-30C轮1.25亿美元HummingbirdAdams Street PartnersLibertus CapitalTime BioVenturesPacific 8 VenturesFifty YearsCivilization VenturesNorwest Venture PartnersNeoTribeBaillie Gifford
-
2021-06-16B轮5500万美元Four Rivers GroupHummingbirdY CombinatorNorwest Venture PartnersNeoTribe
-
2020-03-10A+轮1500万美元HOF Capital500 StartupsCivilization VenturesPacific 8 VenturesLibertus CapitalY CombinatorNeoTribeHummingbird
-
2019-03-28A轮1500万美元NeoTribeHummingbirdHOF CapitalY CombinatorCivilization Ventures
- 加载更多
相关投融资企业
B轮
星辰海医疗成立于2020年10月，是一家专注于内窥镜介入诊疗业务的医疗科技公司，旨在向全球提供涵盖泌尿、呼吸、消化等科室的内窥镜介入诊疗整体解决方案，让疾病更早被发现，让患者更好被治疗。内窥镜诊疗是非血管微创介入的重要组成部分，广泛分布于消化科、泌尿科、呼吸、耳鼻喉科、普外科以及妇科等。
D轮
Cytovale是一个由生物学家，数据科学家和工程师组成的团队，致力于开发机械生物标志物以改善人类健康。 Cytovale的新型微流体平台允许 Cytovale,Inc探测单个细胞以量化疾病的机械特征。 Cytovale首先将其应用于败血症，这种疾病的早期检测可显着改善患者预后并降低治疗成本。
未公开
Billiontoone Inc is a developer of a molecular counter platform intended to improve the resolution of cell-free DNA testing. The company's prenatal testing procedure focuses on quantitative biology and statistical learning methods to optimize the signal-to-noise ratio and detect single-gene disorders, enabling expecting mothers to detect disorders such as sickle-cell disease, beta-thalassemia, spinal muscular atrophy, and cystic fibrosis through a simple blood test.In December 2022, Billiontoone Inc announces it has secured an additional $48.5 million of funding from existing equity investors as well as upsized its Term Loan Facility with access to up to $35 million With this additional funding, gross proceeds will reach $280 million.In March 2022, BillionToOne Inc closed an oversubscribed Series C funding round of $125 million with premier global investors
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息